Estogel is a topical hormone replacement therapy containing estradiol at a concentration of 0.06% w/w, designed to alleviate symptoms associated with estrogen deficiency in postmenopausal women. Estradiol, a form of estrogen, helps restore hormonal balance by supplementing the body's natural estrogen levels, thereby reducing common menopausal symptoms such as hot flashes, night sweats, vaginal dryness, and mood swings. Applied once daily to clean, dry skin, typically on the arms or legs, Estogel is absorbed transdermally, providing a steady release of estradiol into the bloodstream while minimizing first-pass metabolism in the liver. This mode of administration offers a convenient and non-invasive alternative to oral estrogen therapies, with a potentially lower risk of gastrointestinal side effects. Estogel is contraindicated in patients with known or suspected estrogen-dependent neoplasia, undiagnosed vaginal bleeding, active or history of thromboembolic disorders, or liver dysfunction. Common side effects may include skin irritation at the application site, breast tenderness, and headache. Patients should use Estogel under medical supervision, with regular monitoring to assess efficacy and safety, and to adjust dosage as needed. It is important to follow prescribed instructions carefully to achieve optimal therapeutic outcomes and minimize risks.